PM-PHD-NTM: Multicentric Retrospective Study of Perinatal Mortality

Sponsor
Corporacion Parc Tauli (Other)
Overall Status
Recruiting
CT.gov ID
NCT05491772
Collaborator
Hospital Sant Joan de Deu (Other), Hospital Clínic Sede Maternitat (Other)
468
1
28.9
16.2

Study Details

Study Description

Brief Summary

Background: Perinatal mortality ranges mortality from 22 gestational weeks up to the first 7 days of life and extended mortality goes up to 28 days of life. The perinatal mortality rate is the most sensitive index of the health status of women and their offspring and of the quality of maternal and child health services. Per our knowledge, there is no study that evaluates perinatal mortality in Catalonia, although household data are available from each hospital. Moreover, the official records usually do not match with the household surveys due to lack of clarity on the definitions. Aim: the aim of the study is to compare the WHO perinatal mortality classification following the ICD-PM in comparison with the used classification. Methodology: Multicentric retrospective study. Data from Sant Joan de Déu, Maternitat Clinic and Parc Taulí hospitals.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    468 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Clasificación y Factores de Riesgo de la Mortalidad Perinatatal
    Anticipated Study Start Date :
    Aug 5, 2022
    Anticipated Primary Completion Date :
    Dec 31, 2022
    Anticipated Study Completion Date :
    Dec 31, 2024

    Outcome Measures

    Primary Outcome Measures

    1. International Classification of Disease (10th Revision)- Perinatal Mortalitymaternal condition group [through study completion, an average of 1 year]

      The ICD-PM provides a standardised system for classifying perinatal mortality (including stillbirths) based on time of death (antepartum or intrapartum) into fetal and maternal causes thereby enabling comparisons within and between diverse settings and contexts

    2. International Classification of Disease (10th Revision)- Perinatal Mortality cause of death [through study completion, an average of 1 year]

      The ICD-PM provides a standardised system for classifying perinatal mortality (including stillbirths) based on time of death (antepartum or intrapartum) into fetal and maternal causes thereby enabling comparisons within and between diverse settings and contexts

    Secondary Outcome Measures

    1. Obstetric history [through study completion, an average of 1 year]

      number of pregnancies, number of total live births, number of deceased babies, number of stillbirths, number of neonatal deaths, number of abortions

    2. Mother's age [through study completion, an average of 1 year]

      age

    3. Type of pregnancy [through study completion, an average of 1 year]

      singleton, twins

    4. Antenatal care number of visits [through study completion, an average of 1 year]

      number

    5. Malaria profilaxis [through study completion, an average of 1 year]

      yes, no

    6. HIV status [through study completion, an average of 1 year]

      positive, negative

    7. Syphilis test [through study completion, an average of 1 year]

      positive, negative

    8. Mother's LMP [through study completion, an average of 1 year]

      date of the last menstrual period

    9. Date of birth [through study completion, an average of 1 year]

      date

    10. Gestational age [through study completion, an average of 1 year]

      weeks

    11. Place of delivery [through study completion, an average of 1 year]

      facility, home, road, others

    12. Onset of labour [through study completion, an average of 1 year]

      spontaneous, induced, cesarean before onset

    13. Fetal heart sounds on admission [through study completion, an average of 1 year]

      yes, no

    14. Partograph used [through study completion, an average of 1 year]

      yes, no

    15. Mode of delivery [through study completion, an average of 1 year]

      vaginal, vaginal assisted, cesarean

    16. Time between decision for action and birth [through study completion, an average of 1 year]

      not applicable, < 30 min, 30 - 60 min, > 60 min

    17. Apgar Score [through study completion, an average of 1 year]

      Apgar Score (min 0, max 10). Higher scores means better outcome

    18. Resuscitation [through study completion, an average of 1 year]

      not necessary, suction, stimulation, ventilation, cardiac compressions, not done

    19. Sex of baby [through study completion, an average of 1 year]

      male, female, unknown

    20. Birth weight [through study completion, an average of 1 year]

      grams

    21. Date of death [through study completion, an average of 1 year]

      Date

    22. Type of death [through study completion, an average of 1 year]

      neonatal, intrapartum or antepartum or unknown timing stillbirth

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    0 Days to 28 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • stillbirths more than 22 weeks of gestation

    • neonatal deaths up to 28 days of life

    Exclusion Criteria:
    • avortions more than 22 weeks of gestation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CorporacionPT Sabadell Barcelona Spain 08208

    Sponsors and Collaborators

    • Corporacion Parc Tauli
    • Hospital Sant Joan de Deu
    • Hospital Clínic Sede Maternitat

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Nuria Torre-Monmany, Principal Investigator, Corporacion Parc Tauli
    ClinicalTrials.gov Identifier:
    NCT05491772
    Other Study ID Numbers:
    • Perinatal mortality - pHD NTM
    First Posted:
    Aug 8, 2022
    Last Update Posted:
    Aug 8, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Nuria Torre-Monmany, Principal Investigator, Corporacion Parc Tauli
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 8, 2022